1. Home
  2. KRYS vs GSAT Comparison

KRYS vs GSAT Comparison

Compare KRYS & GSAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Krystal Biotech Inc.

KRYS

Krystal Biotech Inc.

HOLD

Current Price

$244.20

Market Cap

6.3B

Sector

Health Care

ML Signal

HOLD

Logo Globalstar Inc.

GSAT

Globalstar Inc.

HOLD

Current Price

$72.90

Market Cap

7.5B

ML Signal

HOLD

Company Overview

Basic Information
Metric
KRYS
GSAT
Founded
2015
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Telecommunications Equipment
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
6.3B
7.5B
IPO Year
2017
2006

Fundamental Metrics

Financial Performance
Metric
KRYS
GSAT
Price
$244.20
$72.90
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
9
4
Target Price
$214.22
$52.75
AVG Volume (30 Days)
277.7K
790.6K
Earning Date
11-03-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
275.72
N/A
EPS
6.66
N/A
Revenue
$373,164,000.00
$262,202,000.00
Revenue This Year
$36.14
$10.89
Revenue Next Year
$41.80
$10.07
P/E Ratio
$36.79
N/A
Revenue Growth
54.51
8.54
52 Week Low
$122.80
$17.24
52 Week High
$248.60
$74.88

Technical Indicators

Market Signals
Indicator
KRYS
GSAT
Relative Strength Index (RSI) 81.72 73.78
Support Level $213.83 $58.02
Resistance Level $241.65 $70.83
Average True Range (ATR) 7.53 3.44
MACD 2.17 0.59
Stochastic Oscillator 89.34 90.31

Price Performance

Historical Comparison
KRYS
GSAT

About KRYS Krystal Biotech Inc.

Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.

About GSAT Globalstar Inc.

Globalstar Inc is a telecommunications company that derives revenue from the provision of mobile satellite services. Mobile satellite services are typically used by customers where existing terrestrial wireline and wireless communications networks are impaired or do not exist. The company provides communications services such as two-way voice and data transmission. In addition, one-way data transmission is also offered. Both services are offered using mobile or fixed devices. The company is an owner of satellite assets. It has one reportable segment: MSS business. The company generates the vast majority of its revenue within the United States.

Share on Social Networks: